Arcadia Biosciences, Inc.
RKDA
$0.47
$0.000.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.56% | -268.72% | 67.13% | 153.10% | -520.17% |
| Total Depreciation and Amortization | -100.00% | -93.16% | -98.83% | -95.54% | -86.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 102.62% | 189.90% | -101.44% | -3,262.07% | 185.17% |
| Change in Net Operating Assets | 126.71% | 45.51% | 207.01% | 447.28% | -377.54% |
| Cash from Operations | 84.31% | 30.79% | 61.02% | 85.33% | 17.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -- | -94.45% |
| Cash from Investing | -- | -- | -100.00% | -100.00% | -94.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -75.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 35,780.00% | -- | -75.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 280.82% | 164.17% | -381.37% | 83.67% | -181.53% |